Successful trial results in the next few years could save thousands of lives and generate billions in new annual revenue for ...

AbbVie's (NYSE:ABBV) autoimmune disease biologic Humira (adalimumab) and Pfizer (NYSE:PFE)/BioNTech's (BNTX) COVID-19 shot Comirnaty are projected to not make it into a list of the top 10 drugs ...

So far, the president has received: Supplemental oxygen An antibody cocktail developed by Regeneron (REGN ... ongoing across the world. Here's what we know about the drugs Trump has been taking ...

Our analyst team just revealed what they believe are the 10 best ... of new drugs. At the time, GSK made a $300 million equity investment in 23andMe, which is more than the amount Regeneron ...

So Dupixent should remain one of the top-selling drugs in the world for the foreseeable future, and help pull Regeneron's revenue in the right direction. The loss of patent exclusivity for Eylea ...

Regeneron said, however, that just one case of CRS was grade 3, which it maintains is lower than other drugs in the class ... to San Francisco! (July 8-10, 2025).